血小板白蛋白比值在肿瘤预后中的应用
The Application of Platelet-Albumin Ratio in Tumor Prognosis
DOI: 10.12677/acm.2026.162407, PDF,   
作者: 周 鑫, 吴志伟, 黄艳茜, 罗 云, 黄 曦*：重庆医科大学附属第二医院血液内科，重庆；郭政军：重庆医科大学附属第二医院肿瘤科，重庆；李星欣：重庆医科大学实验教学管理中心，重庆；胡艳妮：重庆医科大学附属儿童医院血液内科，重庆
关键词: 血小板白蛋白比值；肿瘤预后；炎症标志物；Platelet-Albumin Ratio； Tumor Prognosis； Inflammatory Marker
摘要: 肿瘤的预后评估对临床治疗和患者管理至关重要。目前，炎症在肿瘤发生发展中的作用被不断深入认识，越来越多的炎症相关指标被用于评估肿瘤预后。血小板白蛋白比值(PAR)作为一种新兴的炎症标志物，近年来在肿瘤预后评估中逐渐受到关注。现有研究表明，PAR在不同类型肿瘤中的预后价值逐渐显现，许多研究亦显示其在肿瘤预后评估中具有独特优势。文章综述了PAR在不同肿瘤中的应用现状，分析了相关研究成果，并探讨了其可能的生物学机制。通过深入研究PAR的临床应用，旨在为肿瘤患者的管理提供新的思路和方法，推动该领域的进一步研究与应用。
Abstract: The prognosis evaluation of tumors is crucial for clinical therapeutics and patient management. In recent years, there has been an increasing understanding of the role of inflammation in tumor oncogenesis and progression, with more and more inflammation-related markers being used to assess tumor prognosis. The platelet-albumin ratio (PAR), as an emerging inflammatory marker, has gradually gained attention in tumor prognosis evaluation. Existing studies indicate that its prognostic value is becoming evident in different types of tumors, and numerous investigations have demonstrated its unique advantages in prognostic evaluation. This article reviews the current application status of PAR in different tumors, analyzes relevant research findings, and explores its possible biological mechanisms. By delving into the clinical application of PAR, it aims to provide new ideas and methods for the management of tumor patients and promote further research and application in this field.
文章引用：周鑫, 郭政军, 李星欣, 胡艳妮, 吴志伟, 黄艳茜, 罗云, 黄曦. 血小板白蛋白比值在肿瘤预后中的应用[J]. 临床医学进展, 2026, 16(2): 403-409. https://doi.org/10.12677/acm.2026.162407

参考文献

[1] Wilber, A. (2010) Roles of Inflammation in Cancer Initiation Progression and Metastasis. Frontiers in Bioscience, 2, 176-183. [Google Scholar] [CrossRef] [PubMed]
[2] Yu, L., Jiang, R., Chen, W., Liu, Y., Wang, G., Gong, X., et al. (2023) Novel Prognostic Indicator Combining Inflammatory Indicators and Tumor Markers for Gastric Cancer. World Journal of Surgical Oncology, 21, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[3] Bacha, S., Sghaier, A., Habibech, S., et al. (2017) Combined C-Reactive Protein and Neutrophil to Lymphocyte Ratio Use Predict Survival Innon-Small-Cell Lung Cancer. La Tunisie Médicale, 95, 229-235.
[4] Wang, B., Wang, Z., Wang, K., Shao, Z., Chen, H., Xu, L., et al. (2024) Inflammatory Markers Correlate with Lymphocytes Infiltrating and Predict Immunotherapy Prognosis for Esophageal Cancer. Future Oncology, 20, 3267-3278. [Google Scholar] [CrossRef] [PubMed]
[5] Tan, J., Song, G., Wang, S., Dong, L., Liu, X., Jiang, Z., et al. (2022) Platelet-To-Albumin Ratio: A Novel Iga Nephropathy Prognosis Predictor. Frontiers in Immunology, 13, Article 842362. [Google Scholar] [CrossRef] [PubMed]
[6] Huang, J., Lu, J., Jiang, F. and Song, T. (2023) Platelet/Albumin Ratio and Plateletcrit Levels Are Potential New Biomarkers for Assessing Endoscopic Inflammatory Bowel Disease Severity. BMC Gastroenterology, 23, Article No. 393. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, C., Bai, Z., Hu, Q., Lv, X., Zeng, S. and Huang, H. (2025) The Platelet-to-Albumin Ratio and the Lactate Dehydrogenase-to-Albumin Ratio Can Serve as Predictors of All-Cause Mortality in Patients with Sepsis. Revista de Investigación Clínica, 77, Article ID: 100009. [Google Scholar] [CrossRef] [PubMed]
[8] Anvari, S., Osei, E. and Maftoon, N. (2021) Interactions of Platelets with Circulating Tumor Cells Contribute to Cancer Metastasis. Scientific Reports, 11, Article No. 393. [Google Scholar] [CrossRef] [PubMed]
[9] Tesfamariam, B. (2016) Involvement of Platelets in Tumor Cell Metastasis. Pharmacology & Therapeutics, 157, 112-119. [Google Scholar] [CrossRef] [PubMed]
[10] Rab, S.O., Altalbawy, F.M.A., Bishoyi, A.K., Ballal, S., Kareem, M., Singh, A., et al. (2025) Targeting Platelet-Tumor Cell Interactions: A Novel Approach to Cancer Therapy. Medical Oncology, 42, Article No. 232. [Google Scholar] [CrossRef] [PubMed]
[11] Luo, G., Zhu, S., He, L., Liu, Q., Xu, C., Yao, Q., et al. (2025) Platelets Promote Metastasis of Intrahepatic Cholangiocarcinoma through Activation of TGF-β/Smad2 Pathway. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1871, Article ID: 167734. [Google Scholar] [CrossRef] [PubMed]
[12] Yu, L., Guo, Y., Chang, Z., Zhang, D., Zhang, S., Pei, H., et al. (2021) Bidirectional Interaction between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies. Frontiers in Oncology, 11, Article 764119. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, J., Zhang, X., Tang, M., Zhang, Q., Deng, L., Song, C., et al. (2024) Comprehensive Evaluation of Serum Hepatic Proteins in Predicting Prognosis among Cancer Patients with Cachexia: An Observational Cohort Study. BMC Cancer, 24, Article No. 293. [Google Scholar] [CrossRef] [PubMed]
[14] Crișan, D., Procopeț, B., Crăciun, R., Ștefănescu, H., Gheorghe, L., Sporea, I., et al. (2025) The Role of Easy-to-Use Non-Invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis—Data from the Romanian Hepatocellular Carcinoma Registry. Journal of Gastrointestinal and Liver Diseases, 34, 205-213. [Google Scholar] [CrossRef] [PubMed]
[15] Anraku, M., Chuang, V.T.G., Maruyama, T. and Otagiri, M. (2013) Redox Properties of Serum Albumin. Biochimica et Biophysica Acta (BBA)—General Subjects, 1830, 5465-5472. [Google Scholar] [CrossRef] [PubMed]
[16] Hanafi, A.R., Jayusman, A.M., Sutandyo, N., Kurniawati, S., Setiawan, L., Diandra, A., et al. (2022) Clinical Laboratory Results as Prognosis Marker in Advanced Stage Non-Small Cell Lung Cancer (NSCLC) in Indonesia. Cureus, 14, e29386. [Google Scholar] [CrossRef] [PubMed]
[17] Tian, H., Liu, Z., Zhang, Z., Zhang, L., Zong, Z., Liu, J., et al. (2023) Clinical Significance of Fibrinogen and Platelet to Pre-Albumin Ratio in Predicting the Prognosis of Advanced Gastric Cancer. Journal of Inflammation Research, 16, 4373-4388. [Google Scholar] [CrossRef] [PubMed]
[18] Li, C., Peng, W., Zhang, X., Wen, T. and Chen, L. (2019) The Preoperative Platelet to Albumin Ratio Predicts the Prognosis of Hepatocellular Carcinoma Patients without Portal Hypertension after Liver Resection. Medicine, 98, e17920. [Google Scholar] [CrossRef] [PubMed]
[19] Peri, V., Lee, E., Fink, M., Starkey, G., Nikfarjam, M., Yoshino, O., et al. (2023) A Single Centre Experience with Pre-Operative Markers in the Prediction of Outcomes after Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery, 27, 1376-1386. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, S., Ma, W., Cao, F., Shen, L., Qi, H., Xie, L., et al. (2020) Hepatocellular Carcinoma within the Milan Criteria: A Novel Inflammation-Based Nomogram System to Assess the Outcomes of Ablation. Frontiers in Oncology, 10, Article 1764. [Google Scholar] [CrossRef] [PubMed]
[21] Carr, B.I., Bag, H.G. and Yilmaz, S. (2024) Peripheral Blood Platelet Counts Identify Prognostically Diverse Clinical Phenotypes in Hepatocellular Carcinoma. Annals of Gastroenterology and the Digestive System, 7, Article 1081.
[22] Guo, M., Sun, T., Zhao, Z. and Ming, L. (2021) Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer. Annals of Thoracic and Cardiovascular Surgery, 27, 84-90. [Google Scholar] [CrossRef] [PubMed]
[23] Lei, Y., Cao, C., Tang, R. and Liu, Y. (2025) Peripheral Blood Inflammatory Biomarkers Neutrophil/ Lymphocyte Ratio, Platelet/lymphocyte Ratio and Systemic Immune-Inflammation Index/Albumin Ratio Predict Prognosis and Efficacy in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy and Opioids. BMC Cancer, 25, Article No. 664. [Google Scholar] [CrossRef] [PubMed]
[24] Urakçı, Z., Oruc, Z., Kömek, H., Ebinç, S., Pirinççi, E., Kalkan, Z., et al. (2025) Comparison of Inflammatory Indices in Patients with Metastatic Non-Small Cell Lung Cancer. Revista da Associação Médica Brasileira, 71, e20240411. [Google Scholar] [CrossRef] [PubMed]
[25] Wei, S., Shao, J., Wang, J. and Wang, G. (2022) The Preoperative Hemoglobin, Albumin, Lymphocyte, and Platelet Score Is a Prognostic Factor for Non-Small Cell Lung Cancer Patients Undergoing Adjuvant Chemotherapy: A Retrospective Study. Annals of Translational Medicine, 10, 457-457. [Google Scholar] [CrossRef] [PubMed]
[26] Feng, Y., Qiao, H., Han, X. and Tang, H. (2024) A Prognostic Nomogram of Non-Small Cell Lung Cancer Based on Tumor Marker Inflammatory Nutrition Score. Translational Lung Cancer Research, 13, 3392-3406. [Google Scholar] [CrossRef] [PubMed]
[27] Patir, P., Cerci, K. and Kurtoglu, E. (2024) Prognostic Evaluation of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Hematological Indices in Classic Hodgkin Lymphoma. International Journal of Laboratory Hematology, 47, 68-78. [Google Scholar] [CrossRef] [PubMed]
[28] Peng, Y., Jiang, T., Chen, S., Tang, X., Zhang, Y., Li, L., et al. (2025) Nutritional and Immune-Inflammatory Scoring System for Predicting Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients. Frontiers in Nutrition, 12, Article 1591508. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, J., Li, L., Yu, F., Zhang, J., Mao, L., Chen, B., et al. (2023) Development and Validation of Platelet-to-Albumin Ratio as a Clinical Predictor for Diffuse Large B-Cell Lymphoma. Frontiers in Oncology, 13, Article 1138284. [Google Scholar] [CrossRef] [PubMed]
[30] Zhou, W., Yang, L., Nie, L. and Lin, H. (2021) Unraveling the Molecular Mechanisms between Inflammation and Tumor Angiogenesis. American Journal of Cancer Research, 11, 301-317.
[31] Jakab, A., Patai, Á.V., Darvas, M., Tormássi-Bély, K. and Micsik, T. (2024) Microenvironment, Systemic Inflammatory Response and Tumor Markers Considering Consensus Molecular Subtypes of Colorectal Cancer. Pathology and Oncology Research, 30, Article ID: 1611574. [Google Scholar] [CrossRef] [PubMed]
[32] Takeichi, N. (1989) [Enhancement of Cancer Growth and Metastasis by Host Reactive Cells and Their Secreting Factors]. Gan To Kagaku Ryoho, 16, 3379-3385.
[33] Yu, M., Jin, Y., Yuan, K., Liu, B., Zhu, N., Zhang, K., et al. (2024) Effects of Exosomes and Inflammatory Response on Tumor: A Bibliometrics Study and Visualization Analysis via Citespace and Vosviewer. Journal of Cancer Research and Clinical Oncology, 150, Article No. 405. [Google Scholar] [CrossRef] [PubMed]
[34] Qin, D., Huang, K., Yao, Z., Xi, P., Jiang, L., Wei, R., et al. (2025) Development of a Nomogram Integrating Modified Inflammation-Based Indexes for Predicting Overall Survival in Pancreatic Cancer: A Retrospective Study. Journal of Inflammation Research, 18, 4813-4830. [Google Scholar] [CrossRef] [PubMed]
[35] Matsui, Y., Matsuda, A., Maejima, A., Shinoda, Y., Nakamura, E., Komiyama, M., et al. (2022) The Clinical Significance of Perioperative Inflammatory Index as a Prognostic Factor for Patients with Retroperitoneal Soft Tissue Sarcoma. International Journal of Clinical Oncology, 27, 1093-1100. [Google Scholar] [CrossRef] [PubMed]

为你推荐